Table 1 Characteristics of patients treated with RNU for upper urinary tract carcinoma
Preoperative factors | n = 73 (%) | |
|---|---|---|
Age (years) | Median (IQR 25–75) | 74 (67–79) |
Gender | Male/female | 56 (76.7)/17 (23.3) |
Laterality | Right/left | 37 (50.7)/36 (49.3) |
Location of main tumor | Ureter/renal pelvis | 33 (45.2)/40 (54.8) |
Hydronephrosis | Yes/no | 24 (32.9)/49 (67.1) |
Urine cytology | Positive/negative | 32 (43.8)/41 (56.2) |
Urinary BTA | Positive/negative | 29 (39.7)/44 (60.3) |
Urinary NMP22 | Positive/negative | 36 (49.3)/37 (50.7) |
Diagnostic ureteroscopic biopsy | Yes/no | 24 (32.9)/49 (67.1) |
Intraoperative and postoperative factors | ||
Pneumoretroperitoneum time (min) | Median (IQR 25–75) | 202 (170–268) |
≥ 210/ < 210 | 32 (43.8)/41 (56.2) | |
Total operating time (min) | median (IQR 25–75) | 352 (302–402) |
≥ 360/ < 360 | 32 (43.8)/41 (56.2) | |
Multifocality | multiple/ single | 11 (15.1)/62 (84.9) |
Tumor size (cm) | ≥ 3/ < 3 | 40 (54.8)/33 (43.8) |
Pathological T stage | ≤ 1/2/ ≥ 3 | 30 (41.1)/18 (24.7)/25 (34.2) |
Grade | 1, 2/3 | 37 (50.7)/36 (49.3) |
LVI | Positive/negative | 18 (24.7)/55 (75.3) |
INF | a/b, c | 21 (28.8)/52 (71.2) |
ASC | Yes/ no | 23 (31.5)/50 (68.5) |